HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Parfums Givenchy v. Drug Emporium

This article was originally published in The Rose Sheet

Executive Summary

Parfums Givenchy v. Drug Emporium: Defendant files a petition for a writ of certiorari Jan. 19 requesting that the Supreme Court overturn a U.S. Court of Appeals for the Ninth Circuit decision preventing Drug Emporium from selling the copyrighted box for Givenchy's Amarige scent. The filing argues that, if the appeals court decision stands, "by the simple expedient of preparing a label or package design and copyrighting it, any foreign producer of any consumer product can control all U.S. competition in its product in the United States -- particularly price competition." On Jan. 12, the appeals court denied the drug chain's request that it reconsider its decision. Givenchy will file a response to the writ within 30 days of the filing...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS001286

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel